Omega Healthcare Files 10-K, Highlights $500M Buyback Program

TL;DR

**Omega Healthcare's 10-K confirms a $500M stock buyback, signaling management's confidence.**

AI Summary

Omega Healthcare Investors Inc. filed its 10-K on February 12, 2024, for the fiscal year ending December 31, 2023. The filing details their financial position, including a $500 million stock repurchase program approved on January 27, 2022. This matters to investors because it indicates management's confidence in the company's valuation and can potentially boost shareholder value by reducing the number of outstanding shares.

Why It Matters

The $500 million stock repurchase program signals management's belief that the stock is undervalued, which could lead to increased share price and earnings per share for existing shareholders.

Risk Assessment

Risk Level: medium — While a stock repurchase program can be positive, the overall risk depends on the company's debt levels and future earnings stability, which are not fully detailed in this snippet.

Analyst Insight

An investor might view the $500 million stock repurchase program as a positive signal, suggesting the company believes its shares are undervalued. This could prompt further research into the company's financial health and potentially lead to considering an investment.

Key Numbers

• $500,000,000 — Stock Repurchase Program (Indicates management's commitment to returning capital to shareholders and potentially boosting share value.)

Key Players & Entities

• OMEGA HEALTHCARE INVESTORS INC (company) — the company filing the 10-K
• $500,000,000 (dollar_amount) — the value of the stock repurchase program
• January 27, 2022 (date) — the approval date of the stock repurchase program
• December 31, 2023 (date) — the end of the fiscal year reported

Forward-Looking Statements

• The stock repurchase program will likely lead to a decrease in outstanding shares. (OMEGA HEALTHCARE INVESTORS INC) — high confidence, target: P12M

FAQ

From the Filing

0000888491-24-000007.txt : 20240212 0000888491-24-000007.hdr.sgml : 20240212 20240212100725 ACCESSION NUMBER: 0000888491-24-000007 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 162 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240212 DATE AS OF CHANGE: 20240212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 24617836 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 10-K 1 ohi-20231231x10k.htm 10-K 0000888491 2023 FY false 0 0 http://fasb.org/us-gaap/2023#OtherAssets http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent 0 0 http://fasb.org/us-gaap/2023#IncomeLossFromEquityMethodInvestments http://fasb.org/us-gaap/2023#IncomeLossFromEquityMethodInvestments http://fasb.org/us-gaap/2023#IncomeLossFromEquityMethodInvestments false false false false false false P8Y P3Y P3M 9900000 P10Y http://fasb.org/us-gaap/2023#OtherAssets http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent 9900000 15000000 15000000 1 0 P12M P4Y 2023 0000888491 ohi:FiveHundredMillionStockRepurchaseProgramMember 2022-01-27 0000888491 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000888491 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0000888491 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0000888491 ohi:DividendReinvestmentAndCommonStockPurchasePlanMember 2023-01-01 2023-12-31 0000888491 ohi:DividendReinvestmentAndCommonStockPurchasePlanMember 2022-01-01 2022-12-31 0000888491 ohi:DividendReinvestmentAndCommonStockPurchasePlanMember 2021-01-01 2021-12-31 0000888491 us-gaap:RetainedEarningsMember 2023-12-31 0000888491 us-gaap:ParentMember 2023-12-31 0000888491 us-gaap:NoncontrollingInterestMember 2023-12-31 0000888491 us-gaap:CommonStockMember 2023-12-31 0000888491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2023-12-31 0000888491 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000888491 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2023-12-31 0000888491 us-gaap:RetainedEarningsMember 2022-12-31 0000888491 us-gaap:ParentMember 2022-12-31 0000888491 us-gaap:NoncontrollingInterestMember 2022-12-31 0000888491 us-gaap:CommonStockMember 2022-12-31 0000888491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2022-12-31 0000888491 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000888491 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2022-12-31 0000888491 us-gaap:RetainedEarningsMember 2021-12-31 0000888491 us-gaap:ParentMember 2021-12-31 0000888491 us-gaap:NoncontrollingInterestMember 2021-12-31 0000888491 us-gaap:CommonStockMember 2021-12-31 0000888491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2021-12-31 0000888491 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000888491 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2021-12-31 0000888491 us-gaap:RetainedEarningsMember 2020-12-31 0000888491 us-gaap:ParentMember 2020-12-31 0000888491 us-gaap:NoncontrollingInterestMember 2020-12-31 0000888491 us-gaap:CommonStockMember 2020-12-31 0000888491 us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember 2020-12-31 0000888491 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000888491 us-gaap:AccumulatedDistributionsInExcessOfNetIncomeMember 2020-12-31 0000888491 us-gaap:AccumulatedTranslationAdjustmentMember 2023-12-31 0000888491 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000888491 us-gaap:AccumulatedGainLossN